Clinical and radiological improvement in Gorham-Stout disease after sirolimus treatment.

Franz Barnes-Saldaña,Andrea Venegas-Andrade, Óscar Colin-Martínez,Adolfo Lizardo-Rodríguez, María T García-Romero,Carola Durán-McKinster

Boletin medico del Hospital Infantil de Mexico(2023)

引用 0|浏览6
暂无评分
摘要
Oral sirolimus treatment for GSD inhibits angiogenesis and osteoclastic activity, stimulating bone anabolism and leading to arrested osteolysis progression and improved ossification, quality of life, and patient prognosis. Therefore, sirolimus should be considered a therapeutic option for this rare disease.
更多
查看译文
关键词
sirolimus treatment,disease,gorham-stout
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要